Viridian Therapeutics Inc (NAS:VRDN)
$ 12.34 0.74 (6.38%) Market Cap: 787.57 Mil Enterprise Value: 347.92 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 46/100

Miragen Therapeutics, Inc., Viridian Therapeutics, Inc. - M&A Call Transcript

Oct 28, 2020 / 01:00PM GMT
Release Date Price: $18.9 (+142.35%)
Operator

Good morning, and welcome to the miRagen Therapeutics Viridian acquisition webcast and conference call. (Operator Instructions) Please be advised that this audio presentation is being recorded.

Now I'd like to turn the call over to Jason Leverone, Chief Financial Officer of miRagen. Please proceed.

Jason A. Leverone
Miragen Therapeutics, Inc. - CFO, Secretary & Treasurer

Thank you, operator, and good morning, everyone. Earlier today, we issued a press release that outlined our acquisition of Viridian Therapeutics. This release is available at miragen.com under the Investors tab.

Before we begin, I would like to remind everyone that statements made during this webcast relating to miRagen's expected future performance, future business prospects or future events or plans may include forward-looking statements, as defined under the Private Securities Litigation Reform Act of 1995. All such forward-looking statements are intended to be subject to the safe harbor protection provided by the Reform Act. Actual outcomes and results could differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot